SCHEMBL20919702

SCHEMBL20919702

CNC(=O)c1cc(-c2ccc(C3(C(=O)Nc4ccc(Cl)cn4)CCC3)cc2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 3/20 0.44
IDO1 P14902 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HDAC1 Q13547 2/20 0.42
KDR P35968 1/20 0.42
HTT P42858 1/20 0.42
PTK2 Q05397 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
F10 P00742 1/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20919737 0.89 FFAR2 (0.43) FFAR2IDO1ALDH1A1HDAC1KDR
SCHEMBL20938113 0.88 HDAC1 (0.44) IDO1ALDH1A1HDAC1KDRHTT
SCHEMBL20919682 0.88 HDAC1 (0.44) IDO1ALDH1A1HDAC1KDRHTT
SCHEMBL20919680 0.86 ALDH1A1 (0.60) IDO1ALDH1A1HDAC1KDRHTT
SCHEMBL20919675 0.80 ALDH1A1 (0.58) IDO1ALDH1A1HDAC1LMNA
SCHEMBL20919670 0.80 HDAC1 (0.43) IDO1ALDH1A1HDAC1KDR
SCHEMBL20919699 0.80 IDO1 (0.42) IDO1ALDH1A1HDAC1KDRLMNA
SCHEMBL20919701 0.79 GRM5 (0.39) FFAR2IDO1HDAC1KDR
SCHEMBL20919712 0.78 KDR (0.41) IDO1KDR
SCHEMBL20919674 0.78 IDO1 (0.40) IDO1ALDH1A1HDAC1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3735410-A1 PICOLINAMIDE COMPOUNDS Tempest Therapeutics, Inc. (US) 2020-11-11 EP claimed
WO-2019079614-A1 PICOLINAMIDE COMPOUNDS TEMPEST THERAPEUTICS, INC. (US) 2019-04-25 WO claimed
EP-3735410-A1 PICOLINAMIDE COMPOUNDS Tempest Therapeutics, Inc. (US) 2020-11-11 EP disclosed
WO-2019079614-A1 PICOLINAMIDE COMPOUNDS TEMPEST THERAPEUTICS, INC. (US) 2019-04-25 WO disclosed